Ernexa Therapeutics Inc. (ERNAW) — 10-Q Filings
All 10-Q filings from Ernexa Therapeutics Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Ernexa Narrows Losses, Raises Capital Amid Going Concern Doubts
— Nov 7, 2025 Risk: high
Ernexa Therapeutics Inc. (ERNAW) reported a net loss of $1.2 million for the three months ended September 30, 2025, a significant improvement from the $26.6 mil -
Ernexa's Cash Boosted by Private Placement Amid Going Concern Doubts
— Aug 13, 2025 Risk: high
Ernexa Therapeutics Inc. (ERNAW) reported a net loss of $3.1 million for the three months ended June 30, 2025, and $11.3 million for the six months ended June 3 -
Ernexia Therapeutics Files Q1 2025 10-Q
— May 7, 2025 Risk: medium
Ernexia Therapeutics Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Eterna Therapeutics Inc. and Brooklyn ImmunoTherap -
Eterna Therapeutics Files Q3 2024 10-Q
— Nov 12, 2024 Risk: medium
Eterna Therapeutics Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Brooklyn ImmunoTherapeutics, Inc., reported fin -
Eterna Therapeutics Files Q2 2024 10-Q
— Aug 13, 2024 Risk: medium
Eterna Therapeutics Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as Brooklyn ImmunoTherapeutics, Inc., reported financia -
Eterna Therapeutics Inc. Files 10-Q for Period Ending March 31, 2024
— May 14, 2024 Risk: medium
Eterna Therapeutics Inc. (ERNAW) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. Eterna Therapeutics Inc. filed a 10-Q report for the period endin
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX